Cooling Strategies for Older Adults in the Heat

April 4, 2024 updated by: W. Larry Kenney, Penn State University

Acute and Chronic Interventions to Improve Heat Loss During Uncompensable Humid Heat Stress in Older Adults

The earth's climate is warming, and the number of heat waves has increased in recent years. At the same time, the number of adults over the age of 65 is growing. Humans sweat and increase blood flow to the skin to cool their body when they get hot. Older adults do not do this as well as young adults. This makes it harder to safely be in warm and/or humid conditions. It is important to learn about cooling strategies for older adults to safely be in warm and/or humid conditions.

There is compelling evidence that intermittent hand and forearm cold-water immersion effectively reduces the rise of core temperature during heat stress in older adults. However, it is still unknown if this is an effective cooling strategy for older adults. Furthermore, our laboratory has shown that folic acid supplementation improves blood flow responses in older adults. This may be beneficial to older adults during heat stress.

Study Overview

Detailed Description

Subjects sign an informed consent form and undergo a medical screening prior to participation. The screening includes a physical exam, anthropometry, chemical and lipid profiles.

Subjects participate in 4 experimental trials, 2 while on folic acid supplementation and 2 while on placebo. The order of treatment (folic acid supplementation or placebo) is randomized. Participants will place their hands and forearms in cold tap water intermittently for one of the two trials for each treatment. The order of the hand and forearm immersion trial is randomized for each treatment. The trials are separated by at least five days. For each experiment, core temperature, heart rate, blood pressure, skin temperature, and sweat rate are measured. Each experimental visit will last 2 hours.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: W. Larry Kenney, Ph.D.
  • Phone Number: 814-863-1672
  • Email: w7k@psu.edu

Study Contact Backup

Study Locations

    • Pennsylvania
      • University Park, Pennsylvania, United States, 16802
        • Noll Laboratory
        • Contact:
          • W. Larry Kenney, Ph.D.
          • Phone Number: 814-863-1672
          • Email: w7k@psu.edu
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults aged 65 and older
  • English proficiency

Exclusion Criteria:

  • Chron's disease, diverticulitis, or similar gastrointestinal disease
  • Abnormal resting exercise electrocardiogram (ECG)
  • Tobacco use
  • High-risk determined by the Atherosclerotic Cardiovascular Disease (CVD) Risk Factor Assessment
  • Antiepileptic or antiseizure medications
  • Methotrexate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Folic acid supplementation
5 mg/day folic acid for 6-7 weeks
Participants will be seated at rest in a hot and humid environment. At 2 time points in the experiment, participants will place their hands and forearms in a bucket of cold tap water for 10 minutes.
Participants will be seated at rest in a hot and humid environment.
Placebo Comparator: Control
Cellulose placebo tablet for 6-7 weeks
Participants will be seated at rest in a hot and humid environment. At 2 time points in the experiment, participants will place their hands and forearms in a bucket of cold tap water for 10 minutes.
Participants will be seated at rest in a hot and humid environment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Core temperature
Time Frame: A slope of core temperature for each experimental aim is calculated and reported through study completion, an average of 1 year.
Core temperature will be monitored throughout each 2 hour experimental visit.
A slope of core temperature for each experimental aim is calculated and reported through study completion, an average of 1 year.
Heart rate
Time Frame: A slope of heart rate for each experimental aim is calculated and reported through study completion, an average of 1 year.
Heart rate will be monitored continuously throughout each 2 hour experimental visit.
A slope of heart rate for each experimental aim is calculated and reported through study completion, an average of 1 year.
Blood Pressure
Time Frame: Blood pressure for each experimental aim is recorded and reported through study completion, an average of 1 year.
Blood pressures will be taken every 10 minutes throughout each 2 hour experimental visit.
Blood pressure for each experimental aim is recorded and reported through study completion, an average of 1 year.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Mass
Time Frame: Baseline immediately before beginning the experimental visit and then once again at the end of the 2 hour experimental visit
Body weight measured on a scale
Baseline immediately before beginning the experimental visit and then once again at the end of the 2 hour experimental visit
Skin Temperature
Time Frame: Mean skin temperature for each experimental aim is calculated and reported through study completion, an average of 1 year
Average mean skin temperature
Mean skin temperature for each experimental aim is calculated and reported through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: W. Larry Kenney, Ph.D., The Pennsylvania State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

March 19, 2024

First Submitted That Met QC Criteria

April 4, 2024

First Posted (Actual)

April 5, 2024

Study Record Updates

Last Update Posted (Actual)

April 5, 2024

Last Update Submitted That Met QC Criteria

April 4, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY24458

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Intermittent cold-water hand and forearm immersion

3
Subscribe